Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation

✍ Scribed by Blyth, E.; Clancy, L.; Simms, R.; Ma, C. K. K.; Burgess, J.; Deo, S.; Byth, K.; Dubosq, M.-C.; Shaw, P. J.; Micklethwaite, K. P.; Gottlieb, D. J.

• Book ID: 119975532
• Publisher: American Society of Hematology
• Year: 2013
• Tongue: English
• Weight: 438 KB
• Volume: 121
• Category: Article
• ISSN: 0006-4971
• DOI: 10.1182/blood-2012-08-448977